語系:
繁體中文
English
說明(常見問題)
圖資館首頁
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Accelerated path to cures
~
Bassaganya-Riera, Josep.
Accelerated path to cures
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Accelerated path to curesedited by Josep Bassaganya-Riera.
其他作者:
Bassaganya-Riera, Josep.
出版者:
Cham :Springer International Publishing :2018.
面頁冊數:
viii, 82 p. :ill., digital ;24 cm.
Contained By:
Springer eBooks
標題:
Immunology.
電子資源:
http://dx.doi.org/10.1007/978-3-319-73238-1
ISBN:
9783319732381$q(electronic bk.)
Accelerated path to cures
Accelerated path to cures
[electronic resource] /edited by Josep Bassaganya-Riera. - Cham :Springer International Publishing :2018. - viii, 82 p. :ill., digital ;24 cm.
Chapter 1: Introduction to Accelerated Path to Cures and Precision Medicine in Inflammatory Bowel Disease -- Chapter 2: Computer-Aided Drug Discovery -- Chapter 3: Preclinical Studies: Efficacy and Safety -- Chapter 4: From Nutritional Immunology to Drug Development -- Chapter 5: Development of Synthetic Patient Populations and In Silico Clinical Trials.
Accelerated Path to Cures provides a transformative perspective on the power of combining advanced computational technologies, modeling, bioinformatics and machine learning approaches with nonclinical and clinical experimentation to accelerate drug development. This book discusses the application of advanced modeling technologies, from target identification and validation to nonclinical studies in animals to Phase 1-3 human clinical trials and post-approval monitoring, as alternative models of drug development. As a case of successful integration of computational modeling and drug development, we discuss the development of oral small molecule therapeutics for inflammatory bowel disease, from the application of docking studies to screening new chemical entities to the development of next-generation in silico human clinical trials from large-scale clinical data. Additionally, this book illustrates how modeling techniques, machine learning, and informatics can be utilized effectively at each stage of drug development to advance the progress towards predictive, preventive, personalized, precision medicine, and thus provide a successful framework for Path to Cures.
ISBN: 9783319732381$q(electronic bk.)
Standard No.: 10.1007/978-3-319-73238-1doiSubjects--Topical Terms:
189152
Immunology.
LC Class. No.: QR182.2.I46 / A234 2018
Dewey Class. No.: 616.0790285
Accelerated path to cures
LDR
:02481nmm a2200313 a 4500
001
537596
003
DE-He213
005
20181105164749.0
006
m d
007
cr nn 008maaau
008
190116s2018 gw s 0 eng d
020
$a
9783319732381$q(electronic bk.)
020
$a
9783319732374$q(paper)
024
7
$a
10.1007/978-3-319-73238-1
$2
doi
035
$a
978-3-319-73238-1
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
QR182.2.I46
$b
A234 2018
072
7
$a
MJCM
$2
bicssc
072
7
$a
MED044000
$2
bisacsh
082
0 4
$a
616.0790285
$2
23
090
$a
QR182.2.I46
$b
A169 2018
245
0 0
$a
Accelerated path to cures
$h
[electronic resource] /
$c
edited by Josep Bassaganya-Riera.
260
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2018.
300
$a
viii, 82 p. :
$b
ill., digital ;
$c
24 cm.
505
0
$a
Chapter 1: Introduction to Accelerated Path to Cures and Precision Medicine in Inflammatory Bowel Disease -- Chapter 2: Computer-Aided Drug Discovery -- Chapter 3: Preclinical Studies: Efficacy and Safety -- Chapter 4: From Nutritional Immunology to Drug Development -- Chapter 5: Development of Synthetic Patient Populations and In Silico Clinical Trials.
520
$a
Accelerated Path to Cures provides a transformative perspective on the power of combining advanced computational technologies, modeling, bioinformatics and machine learning approaches with nonclinical and clinical experimentation to accelerate drug development. This book discusses the application of advanced modeling technologies, from target identification and validation to nonclinical studies in animals to Phase 1-3 human clinical trials and post-approval monitoring, as alternative models of drug development. As a case of successful integration of computational modeling and drug development, we discuss the development of oral small molecule therapeutics for inflammatory bowel disease, from the application of docking studies to screening new chemical entities to the development of next-generation in silico human clinical trials from large-scale clinical data. Additionally, this book illustrates how modeling techniques, machine learning, and informatics can be utilized effectively at each stage of drug development to advance the progress towards predictive, preventive, personalized, precision medicine, and thus provide a successful framework for Path to Cures.
650
0
$a
Immunology.
$3
189152
650
0
$a
Immunoinformatics.
$3
224310
650
0
$a
Drug development.
$3
190608
650
1 4
$a
Biomedicine.
$3
273648
650
2 4
$a
Computational Biology/Bioinformatics.
$3
274833
650
2 4
$a
Health Informatics.
$3
274212
650
2 4
$a
Computer Appl. in Life Sciences.
$3
274180
700
1
$a
Bassaganya-Riera, Josep.
$3
814629
710
2
$a
SpringerLink (Online service)
$3
273601
773
0
$t
Springer eBooks
856
4 0
$u
http://dx.doi.org/10.1007/978-3-319-73238-1
950
$a
Biomedical and Life Sciences (Springer-11642)
筆 0 讀者評論
全部
電子館藏
館藏
1 筆 • 頁數 1 •
1
條碼號
館藏地
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
000000157467
電子館藏
1圖書
電子書
EB QR182.2.I46 A169 2018
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
多媒體檔案
http://dx.doi.org/10.1007/978-3-319-73238-1
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入